Correlation Between Merck and Telomir Pharmaceuticals,

Can any of the company-specific risk be diversified away by investing in both Merck and Telomir Pharmaceuticals, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and Telomir Pharmaceuticals, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Merck Company and Telomir Pharmaceuticals, Common, you can compare the effects of market volatilities on Merck and Telomir Pharmaceuticals, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of Telomir Pharmaceuticals,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and Telomir Pharmaceuticals,.

Diversification Opportunities for Merck and Telomir Pharmaceuticals,

0.76

Correlation Coefficient

Merck  Telomir Pharmaceuticals,

Poor diversification

The 3 months correlation between Merck and Telomir is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and Telomir Pharmaceuticals, Commo in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telomir Pharmaceuticals, and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with Telomir Pharmaceuticals,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telomir Pharmaceuticals, has no effect on the direction of Merck i.e., Merck and Telomir Pharmaceuticals, go up and down completely randomly.

Pair Corralation between Merck and Telomir Pharmaceuticals,

Considering the 90-day investment horizon Merck Company is expected to under-perform the Telomir Pharmaceuticals,. But the stock apears to be less risky and, when comparing its historical volatility, Merck Company is 6.56 times less risky than Telomir Pharmaceuticals,. The stock trades about -0.19 of its potential returns per unit of risk. The Telomir Pharmaceuticals, Common is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest  670.00  in Telomir Pharmaceuticals, Common on September 19, 2024 and sell it today you would lose (179.00) from holding Telomir Pharmaceuticals, Common or give up 26.72% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Merck Company  vs.  Telomir Pharmaceuticals, Commo

Merck Company

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Telomir Pharmaceuticals,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Telomir Pharmaceuticals, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Merck and Telomir Pharmaceuticals,

The main advantage of trading using opposite Merck and Telomir Pharmaceuticals, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, Telomir Pharmaceuticals, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telomir Pharmaceuticals, will offset losses from the drop in Telomir Pharmaceuticals,'s long position.

The idea behind Merck Company and Telomir Pharmaceuticals, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.